RARE Historical PE Ratio image   This RARE PE ratio history page last updated 8/1/2022
RARE Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
7/28/2022
51.88-2.26-9.04NA
Q1 2022
5/5/2022
66.43-2.19-8.76NA
Q4 2021
2/10/2022
71.40-1.79-7.16NA
Q3 2021
11/2/2021
84.83-1.08-4.32NA
Q2 2021
8/2/2021
80.84-1.81-7.24NA
Q1 2021
5/4/2021
101.85-2.03-8.12NA
Q4 2020
2/11/2021
162.78-0.37-1.48NA
Q3 2020
10/27/2020
97.44-1.13-4.52NA
Q2 2020
7/30/2020
77.60-1.12-4.48NA
Q1 2020
5/6/2020
66.26-2.05-8.20NA
Q4 2019
2/13/2020
62.90-1.62-6.48NA
Q3 2019
11/5/2019
39.86-1.96-7.84NA
Q2 2019
8/1/2019
60.43-1.72-6.88NA
Q1 2019
5/6/2019
67.25-1.82-7.28NA
Q4 2018
2/19/2019
56.81-1.73-6.92NA
Q3 2018
11/5/2018
52.94-1.74-6.96NA
Q2 2018
8/2/2018
79.58-1.87-7.48NA
Q1 2018
5/7/2018
57.96-2.03-8.12NA
Q4 2017
2/20/2018
48.18-1.52-6.08NA
Q3 2017
11/2/2017
48.25-1.87-7.48NA
Q2 2017
7/27/2017
67.74-1.72-6.88NA
Q1 2017
5/4/2017
61.22-1.63-6.52NA
Q4 2016
2/16/2017
76.82-1.75-7.00NA
Q3 2016
11/7/2016
58.54-1.64-6.56NA
Q2 2016
8/8/2016
65.35-1.46-5.84NA
Q1 2016
5/9/2016
64.36-1.35-5.40NA
Q4 2015
2/25/2016
60.85-1.42-5.68NA
Q3 2015
11/9/2015
102.33-1.03-4.12NA
Q2 2015
8/13/2015
112.30-0.83-3.32NA
Q1 2015
5/11/2015
67.22-0.63-2.52NA
Q4 2014
3/25/2015
56.63-0.52-2.08NA
Q3 2014
11/10/2014
41.16-0.50-2.00NA
Q2 2014
8/11/2014
49.15-0.45-1.80NA
Q1 2014
5/12/2014
34.04-0.85-3.40NA
RARE PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
7/28/2022
51.88-2.26-7.32NA
Q1 2022
5/5/2022
66.43-2.19-6.87NA
Q4 2021
2/10/2022
71.40-1.79-6.71NA
Q3 2021
11/2/2021
84.83-1.08-5.29NA
Q2 2021
8/2/2021
80.84-1.81-5.34NA
Q1 2021
5/4/2021
101.85-2.03-4.65NA
Q4 2020
2/11/2021
162.78-0.37-4.67NA
Q3 2020
10/27/2020
97.44-1.13-5.92NA
Q2 2020
7/30/2020
77.60-1.12-6.75NA
Q1 2020
5/6/2020
66.26-2.05-7.35NA
Q4 2019
2/13/2020
62.90-1.62-7.12NA
Q3 2019
11/5/2019
39.86-1.96-7.23NA
Q2 2019
8/1/2019
60.43-1.72-7.01NA
Q1 2019
5/6/2019
67.25-1.82-7.16NA
Q4 2018
2/19/2019
56.81-1.73-7.37NA
Q3 2018
11/5/2018
52.94-1.74-7.16NA
Q2 2018
8/2/2018
79.58-1.87-7.29NA
Q1 2018
5/7/2018
57.96-2.03-7.14NA
Q4 2017
2/20/2018
48.18-1.52-6.74NA
Q3 2017
11/2/2017
48.25-1.87-6.97NA
Q2 2017
7/27/2017
67.74-1.72-6.74NA
Q1 2017
5/4/2017
61.22-1.63-6.48NA
Q4 2016
2/16/2017
76.82-1.75-6.20NA
Q3 2016
11/7/2016
58.54-1.64-5.87NA
Q2 2016
8/8/2016
65.35-1.46-5.26NA
Q1 2016
5/9/2016
64.36-1.35-4.63NA
Q4 2015
2/25/2016
60.85-1.42-3.91NA
Q3 2015
11/9/2015
102.33-1.03-3.01NA
Q2 2015
8/13/2015
112.30-0.83-2.48NA
Q1 2015
5/11/2015
67.22-0.63-2.10NA
Q4 2014
3/25/2015
56.63-0.52-2.32NA
Q3 2014
11/10/2014
41.16-0.50NANA
Q2 2014
8/11/2014
49.15-0.45NANA
Q1 2014
5/12/2014
34.04-0.85NANA
Quotes delayed 20 minutes

Email EnvelopeFree RARE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Ultragenyx Pharmaceutical (RARE) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

RCEL PE Ratio History
RCKT PE Ratio History
RCUS PE Ratio History
RDNT PE Ratio History
RDUS PE Ratio History
REGN PE Ratio History
REPH PE Ratio History
REPL PE Ratio History
RETA PE Ratio History
RGEN PE Ratio History
How should the RARE historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Ultragenyx Pharmaceutical. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this RARE Historical PE Ratio page.

What is the average historical PE for RARE based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The RARE historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for RARE based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The RARE historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the RARE Historical PE Ratio information for Ultragenyx Pharmaceutical' stock. The average RARE historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average RARE historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this RARE historical PE result, against the recent PE: when this page was posted on 7/29/2022, the most recent closing price for RARE had been 53.28, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on RARE or any other given stock, valuation analysis for RARE can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Ultragenyx Pharmaceutical PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for RARE. Thanks for visiting, and the next time you need to research RARE Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: PTIX Average Annual Return, CHAU Options Chain, BNS Stock Predictions.

 

RARE Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.